Stephen E. Gitelman
- Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset
2026/03/12 by Carmella Evans-Molina, Stephen E. Gitelman, Andrea Mari +1 · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Clinical trial #Diabetes Management and Research #Diabetes and associated disorders #Diabetes mellitus #Disease #Insulin #Pancreatic function and diabetes #Randomized controlled trial #Stage (stratigraphy) #Type 1 diabetes #Type 2 diabetes